Salpharmasp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-01-23
Share capital
80,000.00 PLN
Registered address
ul. Puławska 392, 02-801 Warszawa, Poland
Electronic delivery address
AE:PL-95147-33275-EVCDD-21

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 52 days early.

  • 202512/06/2026
  • 202405/06/2025
  • 202318/06/2024
  • 202228/06/2023
  • 202130/05/2022
  • 202020/05/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 791.54kMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 47.58kMedianUSD 20.66kAverageUSD 86.55k
Operating costs
This companyUSD 737.07kMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 129.66kMedianUSD 544.32kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Salpharma has been an NFZ healthcare provider since 2024. In 2026 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Other services provided in pharmaciesmazowieckie1USD 0.00

Authorized Representatives

Anna Maria Salska – President of the Management Board

Manner of representation

Each member of the management board acting independently.

Ownership

OwnerSharesShare valueStake
Przemysław Wojciech Druszczage 58
400$10,804.9750%
Anna Maria Salskaage 56
400$10,804.9750%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2017-02-04.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $4,512.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,038
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$881
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Cosmedicasp. z o.o.
DR ZdrowieS.A.
MagmaxS.A.
Novopharm - Millersp. j.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.
Nukloversp. z o.o.
Massmedsp. z o.o.
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.
Femaherbsp. z o.o.

Change history

DateEvent
2017-08-09Address change
2017-01-23Entered in the register

FAQ

Last updated: 2026-06-12